These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Control of estrus with prostaglandin F2alpha in mares: minimal effective dose and stage of estrous cycle.
    Author: Oxender WD, Noden PA, Bolenbaugh DL, Hafs HD.
    Journal: Am J Vet Res; 1975 Aug; 36(08):1145-7. PubMed ID: 1171645.
    Abstract:
    To determine the minimal effective dose of prostagiandin (PGF2alpha; tromethamine salt) given subcutaneously (SC), mares of mixed breeding (400 kg av body weight) were given 2-, 3-, 5-, and 10-mg doses from 7 to 9 days after ovulation. In some but not all mares given doses of 2 and 3 mg of PGF2alpha, luteolysis occurred, but doses of 5 or 10 mg of PGF2alpha were luteolytic in all mares. The 10-mg dose of PGF2alpha did not cause luteolysis in mares 1 day after ovulation, and caused luteolysis in only 2 of 5 mares on day 3 after ovulation. The same dose of PGF2alpha, however, caused luteolysis in all mares on days 5 or 7 after ovulation. The results indicate that the minimal effective luteolytic dose of PGF2alpha (free-acid equivalent) is about 9 mug/kg, and that PGF2alpha is effective fromday 5 after ovulation.
    [Abstract] [Full Text] [Related] [New Search]